Q2 2026 · Form 13F LedgerData source: SEC EDGAR  
H

HOLDER.TOP

Who owns what — the quarterly ledger of U.S. institutional holdings.
EN · 简 · 繁
Funds / Foresite Capital Management IV, LLC
Form 13F · Q2 2026

Foresite Capital Management IV, LLC

CIK 1704132Filed 2026-08-1413F-HR View the filing on EDGAR ↗
$290M
Reported book value
6
Positions
12
Quarters on record
Top 50
Positions

Foresite Capital Management IV, LLC — holdings

Top 6 positions of 6, ranked by reported value. Share change is versus the previous quarter.
#SecuritySharesShare Δ QoQValue% of book
1PHVS Pharvaris N V4.8M+0.0%$165M57.0%
2CYTK Cytokinetics Inc714,695+42.0%$61M21.0%
3EIKN Eikon Therapeutics Inc1.9M+0.0%$25M8.7%
4RLAY Relay Therapeutics Inc1.2M+25.0%$23M8.1%
5XENE Xenon Pharmaceuticals Inc160,000+0.0%$10M3.3%
6CRINETICS PHARMACEUTICALS IN Crinetics Pharmaceuticals In150,000—$6M1.9%
Source: Form 13F filings via SEC EDGAR. Positions as of Jun 30, 2026. Options (put/call) are excluded from share counts.